Questions & answers on signal management
This document addresses a number of questions which stakeholders, in particular marketing authorisation holders (MAHs), may have on the management of safety signals. Any questions on signal management that are not addressed in this document should be sent to the European Medicines Agency (EMA) using the general enquiry form (subject: "Signal Management")
Click on this link for more information.
